Synapse - Oxford University Press

Oxford University Press

SHERPA: Yellow

People

Drilon
Motzer
Mellinghoff
Shuman
Rosenblum
Dunkel
Karajannis
Saltz
Souweidane
Panageas

Groups

Department of Medicine (1995)
Solid Tumor Oncology Division (1624)
GSK Faculty (765)
Survivorship Research (639)
Population Sciences Research Program (615)
Epidemiology and Biostatistics (465)
Department of Pathology and Laboratory Medicine (415)
Gastrointestinal Oncology Service (386)
Genitourinary Oncology Service (367)
Tow Center for Developmental Oncology (TCDO) (352)

Search Within

Results (4676)

Export to EndNote / Excel

Phase 3 study of avelumab in combination with axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC)

Meeting Abstract

Motzer, R. J.; Choueiri, T.; Larkin, J.; Albiges, L.; Haanen, J. B.; Schmidinger, M.; Atkins, M. B.; Mariani, M.; Shnaidman, M.; Di Pietro, A.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Exposure-response of olaratumab for survival outcomes and safety when combined with doxorubicin in soft tissue sarcoma (STS) patients

Meeting Abstract

Jones, R.; Mo, G.; Baldwin, J. R.; Nichols, R. D.; Ilaria, R. L.; Conti, I.; Cronier, D. M.; Tap, W. D.
Annals of Oncology (2016)

Fulltext@MSK | Save

The first study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed or refractory low-grade gliomas

Meeting Abstract

Kieran, M. W.; Bouffet, E.; Tabori, U.; Broniscer, A.; Cohen, K.; Hansford, J.; Geoerger, B.; Hingorani, P.; Dunkel, I.; Russo, M.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC

Meeting Abstract

Kowanetz, M.; Zou, W.; Shames, D. S.; Cummings, C.; Rizvi, N.; Spira, A. I.; Frampton, G. M.; Leveque, V.; Flynn, S.; Mocci, S.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Clinical activity of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC) and a BRCA mutation (BRCAmut): Analysis of pooled data from Study 10 (parts 1, 2a, and 3) and ARIEL2 (parts 1 and 2)

Meeting Abstract

Kristeleit, R. S.; Shapira-Frommer, R.; Oaknin, A.; Balmana, J.; Ray-Coquard, I. L.; Domchek, S.; Tinker, A. V.; Castro, C. M.; Welch, S.; Poveda, A. M.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase 1 study of LOXO-101, a selective TRK inhibitor, in pediatric patients with cancer

Meeting Abstract

Laetsch, T. W.; Nagasubramanian, R.; Dubois, S. G.; Mascarenhas, L.; Hawkins, D.; Shukla, N.; Turpin, B.; Smith, S.; Reynolds, M.; Cruickshank, S.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL): A pooled analysis

Meeting Abstract

Long, G. V.; Larkin, J.; Ascierto, P. A.; Hodi, F. S.; Rutkowski, P.; Sileni, V.; Hassel, J.; Lebbe, C.; Pavlick, A. C.; Wagstaff, J.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study

Meeting Abstract

Loriot, Y.; Rosenberg, J. E.; Powles, T. B.; Necchi, A.; Hussain, S.; Morales, R.; Retz, M.; Niegisch, G.; Duran, I.; Theodore, C.; more...
Annals of Oncology (2016)

Fulltext@MSK | Save

Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)